NCT07591428 Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
| NCT ID | NCT07591428 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Alcohol Drinking |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-06-10 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-06-10 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-arm, non-randomized, prospective study to evaluate the feasibility and preliminary efficacy of a 30-day mobile Health (mHealth) Reset Challenge for reducing high-risk drinking.
Eligibility Criteria
Inclusion Criteria: * Adults +18 * Individuals who drink alcohol regularly * Further inclusion criteria will be determined via a Zoom screening with a member of the research staff. * Current Oklahoma Resident Exclusion Criteria: \- Exclusion criteria will be determined via a Zoom screening with a member of the research staff.
Contact & Investigator
Sophia You, PhD, ABPP
PRINCIPAL INVESTIGATOR
University of Oklahoma
Frequently Asked Questions
Who can join the NCT07591428 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Alcohol Drinking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07591428 currently recruiting?
Yes, NCT07591428 is actively recruiting participants. Contact the research team at Dokyoung-You@ou.edu for enrollment information.
Where is the NCT07591428 trial being conducted?
This trial is being conducted at Tulsa, United States.
Who is sponsoring the NCT07591428 clinical trial?
NCT07591428 is sponsored by University of Oklahoma. The principal investigator is Sophia You, PhD, ABPP at University of Oklahoma. The trial plans to enroll 150 participants.